Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase NA 2Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Gastrointestinal 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2Plasma cell 1Other neoplasm 1Myeloid 1Genitourinary 1Dermatologic 1

Conditions

Multiple Myeloma 338Neoplasms, Plasma Cell 62Recurrence 39Lymphoma, Non-Hodgkin 37Leukemia, Lymphocytic, Chronic, B-Cell 35Lymphoma 31Hodgkin Disease 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Immunoglobulin Light-chain Amyloidosis 27Lymphoma, Follicular 26Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, Myeloid, Acute 25Neoplasms 24Burkitt Lymphoma 23Leukemia, Myeloid, Chronic-Phase 22Myeloproliferative Disorders 21Leukemia, Myeloid, Accelerated Phase 21Leukemia 21Blast Crisis 21Primary Myelofibrosis 20Lymphoma, T-Cell, Cutaneous 20Leukemia, Hairy Cell 19Waldenstrom Macroglobulinemia 16Myelodysplastic Syndromes 16Leukemia, Myelomonocytic, Chronic 16Sezary Syndrome 15Mycosis Fungoides 15

Interventions

Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Drug-Related Side Effects and Adverse Reactions × Plasma cell × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡